Current Drug Safety : Impact Factor & More
eISSN: 2212-3911pISSN: 1574-8863
Share this on:
Key Metrics
CiteScore 
2.9
SJR
Q4Toxicology
SNIP
0.68
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Drug Safety
Current Drug Safety Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL |
| Language | English |
| Frequency | Tri-annual |
| General Details | |
| Language | English |
| Frequency | Tri-annual |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Drug Safety
Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.
- 13 Oct 2026
- Current drug safety
Bilateral Lower Extremity Edema During Donepezil Treatment: A Case Report.
- 8 Oct 2026
- Current drug safety
Efficacy and Safety of Sequential Combined Immunomodulatory Systemic Therapies Used in the Management of Refractory Cytokine Release Syndrome in Critically Ill Patients with COVID-19.
- 29 Sep 2026
- Current drug safety
Duality of Rarity of Chemotherapy-induced Flagellate Erythema among Cancer Patients: A Case Report with 26 Years of Evidence in Oncology.
- 25 Sep 2026
- Current drug safety
Pharmacovigilance Knowledge, Attitudes, and ADR Reporting Behaviour Among Physicians and Pharmacists in a Tertiary Hospital
- 21 Sep 2026
- Current Drug Safety
Possible Interaction of the Gut-selective Antibiotic Rifaximin with Carvedilol Associated with Transient Indirect Hyperbilirubinemia: A Case Report.
- 9 Sep 2026
- Current drug safety
Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.
- 13 Oct 2026
- Current drug safety
Bilateral Lower Extremity Edema During Donepezil Treatment: A Case Report.
- 8 Oct 2026
- Current drug safety
Efficacy and Safety of Sequential Combined Immunomodulatory Systemic Therapies Used in the Management of Refractory Cytokine Release Syndrome in Critically Ill Patients with COVID-19.
- 29 Sep 2026
- Current drug safety
Duality of Rarity of Chemotherapy-induced Flagellate Erythema among Cancer Patients: A Case Report with 26 Years of Evidence in Oncology.
- 25 Sep 2026
- Current drug safety
Pharmacovigilance Knowledge, Attitudes, and ADR Reporting Behaviour Among Physicians and Pharmacists in a Tertiary Hospital
- 21 Sep 2026
- Current Drug Safety
Possible Interaction of the Gut-selective Antibiotic Rifaximin with Carvedilol Associated with Transient Indirect Hyperbilirubinemia: A Case Report.
- 9 Sep 2026
- Current drug safety
FAQs on Current Drug Safety
How long has Current Drug Safety been actively publishing? 
What is the publishing frequency of Current Drug Safety?
How many articles did Current Drug Safety publish last year?
What is the eISSN & pISSN for Current Drug Safety?
What is Citescore for Current Drug Safety?
What is SNIP score for Current Drug Safety?
What is the SJR for Current Drug Safety?
Who is the publisher of Current Drug Safety?
